Sermorelin

Sermorelin is a GHRH analog studied for endogenous growth-hormone support, recovery, and body composition, with bedtime use favored to align with natural GH pulsatility.

Profile · 01

Overview

Sermorelin is a GHRH analog discussed for stimulating endogenous growth-hormone release rather than replacing GH directly. The source presents it as a classic bedtime peptide in the broader GH-support category.

Compared with more selective ghrelin mimetics, sermorelin is framed as working upstream through GHRH signaling. This page follows the source's nightly subcutaneous titration pattern.

At a Glance

Goal

Support endogenous growth-hormone release, recovery, and body-composition signaling

Protocol

Suggested once-nightly titration approach with increases every two weeks.

Reconstitute

Add 3.0 mL bacteriostatic water to a 5 mg vial for about 1.67 mg/mL concentration

Typical daily range

200-500 mcg once nightly

Start

200 mcg nightly for Weeks 1-2

Target

400-500 mcg nightly by Weeks 5-8

Frequency

Once nightly (subcutaneous)

Cycle Length

8-12 weeks; the source notes some adult use extends 3-6 months

Timing

Bedtime administration to align with the natural nocturnal GH pulse

Route

Subcutaneous

Cycle

8-12 weeks on, 4 weeks off

Inject once nightly subcutaneously and keep timing consistent. The source treats bedtime use and fasting-window awareness as important because sermorelin is meant to support a discrete endogenous GH pulse rather than flat continuous exposure.

Dose progression

Weeks 1-2

200 mcg (0.2 mg) · 12 units (0.12 mL)

Weeks 3-4

300 mcg (0.3 mg) · 18 units (0.18 mL)

Weeks 5-6

400 mcg (0.4 mg) · 24 units (0.24 mL)

Weeks 7-8

500 mcg (0.5 mg) · 30 units (0.30 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Sermorelin works.

Sermorelin stimulates endogenous GH release through GHRH receptor activity rather than supplying exogenous GH directly. That is why the source emphasizes bedtime alignment and protocol consistency.

It occupies a familiar place in GH-support discussions alongside ipamorelin, CJC-1295, and other secretagogues, though route-specific protocol details still vary across research culture.

Science · 02

Effects

Observations from clinical or preclinical literature.

May support endogenous GH release and downstream IGF-1 signaling

Often discussed for recovery, sleep, and body-composition goals

Bedtime timing aligns naturally with the protocol logic

Water retention, headache, or injection-site irritation may occur

Human outcomes vary and remain less predictable than simple marketing claims suggest

Science · 03

Caution

Use caution in active cancer or significant cancer history because GH-axis signaling can be growth-promoting

Not recommended during pregnancy or breastfeeding because safety data is insufficient

Use caution in diabetes or insulin resistance

Avoid assuming secretagogue use is interchangeable with prescribed GH therapy

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Protein intake

Supports recovery and lean-mass goals downstream of GH signaling.

Magnesium

Supports sleep quality and recovery.

Zinc

Relevant to endocrine and recovery biology.

Sleep hygiene

Critical because the protocol leans on nighttime pulsatility.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain a consistent bedtime and pre-dose fasting rhythm

Use resistance training and adequate protein to reinforce body-composition goals

Prioritize sleep quality because poor sleep undermines the protocol logic

Track appetite, recovery, and sleep together rather than in isolation

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

Sleep quality and recovery - central to the nightly-GH-pulse concept
Body composition - monitor lean-mass and fat-mass trends
Energy and workout recovery - useful functional context markers
Injection-site reactions - note redness, swelling, or discomfort

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

IGF-1

Primary downstream marker of GH-axis response.

Fasting glucose and HbA1c

Useful metabolic markers during GH-secretagogue use.

CBC (Complete Blood Count)

General baseline and follow-up monitoring.

CMP (Comprehensive Metabolic Panel)

Assesses liver and kidney function during the protocol.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length

Vial size

Bac. water

Syringe

Vials

0 × 5 mg each…

Syringes

Bac. water

0 mL

Swabs

02 per syringe

Calculators · 02

Dose Calculator

Vial

Bac. water

Syringe

Dose

Concentration

0mcg/mL

Volume per dose

0mL

…

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

Allow vial to reach room temperature for 15–20 minutes before reconstitution.
Draw the chosen bacteriostatic water volume with a sterile syringe.
Inject slowly down vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully

Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue

Do not aspirate for subcutaneous injections; inject slowly and steadily

Rotate sites across the abdomen, thighs, and upper arms

Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized

Store at room temp in dry, dark conditions; minimize moisture exposure.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile syringe for each injection and dispose of it safely

Consistent bedtime timing is a core part of the protocol design

Document dose, timing, sleep, and recovery trends for consistency

PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

GH-axis literature
Background literature on sermorelin and endogenous GH stimulation.
https://pubmed.ncbi.nlm.nih.gov/
CDC
Subcutaneous injection route guidance.
https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf